PFE vs TGEN · P/E 20, rev $15.03B vs rev $12.1M
Pfizer Inc (PFE) versus Tecogen Inc. (TGEN) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Tecogen Inc. (TGEN) is a electrical equipment & parts company listed on AMEX.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported TGEN revenue for 2026-06-30 was $12.1M. Net income was -$4.3M. Revenue was up 90.7% from 2026-03-31 to 2026-06-30. TGEN currently screens at market cap $172.9M.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. TGEN currently screens at market cap $172.9M.
Not investment advice. Open the PFE and TGEN stock pages for the full models.
Not investment advice.